Paul Johnson
Paul Johnson is scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles
The Development and Application of a Monoclonal Antibody Purification Platform
Paul Johnson;Judy Glynn;Kristin Thomas;Natarajan Ramasubramanyan, PhD;Paul Mensah, PhD;Timothy Hagerty;Gopinath Annathur;Timothy Pabst, PhD
October 2nd 2009A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
The Development and Application of a Monoclonal Antibody Purification Platform
Paul Johnson;Judy Glynn;Kristin Thomas;Natarajan Ramasubramanyan, PhD;Paul Mensah, PhD;Timothy Hagerty;Gopinath Annathur;Timothy Pabst, PhD
March 2nd 2009A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 15th 2024 | Updated: November 20th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 20th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Published: October 22nd 2024 | Updated: November 20th 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 28th 2024 | Updated: November 20th 2024
Quantifying Chemotherapeutic Cytotoxicity in Glial Cells using AI-Driven Label-Free Cell Analysis
